Complicated Pneumonia (CP) in Children in South-East Europe
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorAleksandar Sovtic
About this trial
This retrospective observational study aims to evaluate clinical course of complicated community acquired pneumonia in children, particularly focusing on necrotizing pneumonia cases, as well as determination of etiological agents (viruses and bacteria) and its association to severity and outcomes of the disease. Furthermore, therapeutic approach, complications, short-term and long-term outcomes and the prevention of the disease are to be assessed. The study will encompass data from pediatric centers in the South-East Europe willing to participate in the study, encompassing ten-year period of time.
Eligibility criteria
Qualifiers
Children aged 1 month to 18 years of age
Children diagnosed with complicated community acquired pneumonia (pneumonia with parapneumonic effusion, necrotizing pneumonia and lung abscess)
Children who were hospitalized from January 1st 2014 to April 30th 2024 and required at least 24 hours of hospital stay
Disqualifiers
Children with increased risk for severe lung infections (cystic fibrosis, primary ciliary dyskinesia, immunodeficiencies, congenital lung abnormalities, neurological conditions, chemotherapy)
Children with hospital-acquired pneumonia
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Aleksandar Sovtic
Lead sponsor
Mother and Child Health Institute of Serbia Dr Vukan Cupic
Sponsor institution
Source ClinicalTrials.gov